DATA FORM FOR CANCER STAGING - OVARY
Form # 785-1-040
| CLIN | PATH | TNM FIGO* DEFINITIONS | ||
| CATEGORY STAGE PRIMARY TUMOR (T) | ||||
| TX | Primary tumor cannot be assessed | |||
| T0 | No evidence of primary tumor | |||
| T1 | I | Tumor limited to ovaries (one or both) | ||
| T1a | IA | Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings. | ||
| T1b | IB | Tumor limited to both ovaries; capsules intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings | ||
| T1c | IC | Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites, or peritoneal washings. | ||
| T2 | II | Tumor involves one or both ovaries with pelvic extension | ||
| T2a | IIA | Extension and/or implants on uterus and/or tube(s). No malignant cells in ascites or peritoneal washings | ||
| T2b | IIB | Extension to other pelvic tissues. No malignant cells in ascites or peritoneal washings | ||
| T2c | IIC | Pelvic extension (2a or 2b) with malignant cells in ascites or peritoneal washings. | ||
| T3 | III | Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis &/or N1 and/or regional lymph node metastasis | ||
| T3a | IIIA | Microscopic peritoneal metastasis beyond pelvis | ||
| T3b | IIIB | Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension | ||
| T3c | IIIC | Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension and/or regional lymph node &/or N1 metastasis | ||
| M1 | IV | Distant metastasis (excludes peritoneal metastasis) | ||
| LYMPH NODE (N) | ||||
| NX | Regional lymph nodes cannot be assessed | |||
| N0 | No regional lymph node metastasis | |||
| N1 | Regional lymph node metastasis | |||
| DISTANT METASTASIS (M) | ||||
| MX | Presence of distant metastasis cannot be assessed | |||
| M0 | No distant metastasis | |||
| M1 | Distant metastasis (excludes peritoneal metastasis) | |||
| CLIN | PATH | STAGE GROUPING AJCC/UICC FIGO* | ||||
| IA | T1a | N0 | M0 | IA | ||
| IB | T1b | N0 | M0 | IB | ||
| IC | T1c | N0 | M0 | IC | ||
| IIA | T2a | N0 | M0 | IIA | ||
| IIB | T2b | N0 | M0 | IIB | ||
| IIC | T2c | N0 | M0 | IIC | ||
| IIIA | T3a | N0 | M0 | IIIA | ||
| IIIB | T3b | N0 | M0 | IIIB | ||
| IIIC | T3c | N0 | M0 | IIIC | ||
| Any T | N1 | M0 | ||||
| IV | Any T | Any N | M1 | IV | ||
* FIGO: Federation Internationale de Gynecologie et d'Obstetrique
Note: Liver capsule metastasis is T3/Stage III, liver parenchymal metastasis M1/Stage IV. Pleural effusion must have positive cytology for M1/Stage IV.
THE FINAL STAGE GROUPING (CLINICAL & PATHOLOGICAL) IS THE RESPONSIBILITY OF THE ATTENDING PHYSICIAN.
| Comments: |
| Patient Name: |